A case of non-resolving hemophilia B Leyden in a 42-year-old male (F9 promoter +13 A>G)

Journal of Thrombosis and Haemostasis

Volumn 6, Issue 5, 2008, Pages 885-886

  James, P D ^a   Stakiw, J ^a   Leggo, J ^a   Walker, I ^b   Lillicrap, David ^a  

^a QUEEN S UNIVERSITY   (Canada)

^b MCMASTER UNIVERSITY   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

ANDROGEN RECEPTOR; BINDING PROTEIN; BLOOD CLOTTING FACTOR 9; TESTOSTERONE;

ADULT; ADULTHOOD; ANAMNESIS; ARTICLE; CASE REPORT; GENE MUTATION; GENETIC ASSOCIATION; GENETIC SCREENING; GENETIC TRANSCRIPTION; HEMOPHILIA B; HUMAN; MALE; NUCLEIC ACID BASE SUBSTITUTION; NUCLEOTIDE SEQUENCE; PHYSICAL EXAMINATION; POINT MUTATION; PRIORITY JOURNAL; PROMOTER REGION; TESTOSTERONE BLOOD LEVEL;

ADULT; FACTOR IX; HEMOPHILIA B; HUMANS; MALE; POINT MUTATION; PROMOTER REGIONS (GENETICS);

EID: 42149173720     PISSN: 15387933     EISSN: 15387836     Source Type: Journal    
DOI: 10.1111/j.1538-7836.2008.02940.x     Document Type: Article

References (13)

1. Yoshitake S, Schach BG, Foster DC, Davie EW, Kurachi K. Nucleotide sequence of the gene for human factor IX (antihemophilic factor B). Biochemistry 1985; 24: 3736-50.
2. Giannelli F, Green PM, Sommer SS, Poon M, Ludwig M, Schwaab R, Reitsma PH, Goossens M, Yoshioka A, Figueiredo MS, Brownlee GG. Haemophilia.B: database of point mutations and short additions and deletions -eighth edition. Nucleic Acids Res 1998; 26: 265-8.
3. Bowen DJ. Haemophilia.A and haemophilia B: Molecular insights. Mol Pathol 2002; 55: 1-18.
4. Veltkamp JJ, Meilof J, Remmelts HG, van der Vlerk D, Loeliger EA. Another genetic variant of haemophilia B: Haemophilia B Leyden. Scand J Haematol 1970; 7: 82-90.
5. Briet E, Bertina RM, van Tilburg NH, Veltkamp JJ. Hemophilia B Leyden: A sex-linked hereditary disorder that improves after puberty. N Engl J Med 1982; 306: 788-90.
6. Crossley M, Ludwig M, Stowell KM, De VP, Olek K, Brownlee GG. Recovery from hemophilia B Leyden: An androgen-responsive element in the factor IX promoter. Science 1992; 257: 377-9.
7. Reitsma PH, Mandalaki T, Kasper CK, Bertina RM, Briet E. Two novel point mutations correlate with an altered developmental expression of blood coagulation factor IX (hemophilia B Leyden phenotype). Blood 1989; 73: 743-6.
8. Crossley PM, Winship PR, Black A, Rizza CR, Brownlee GG. Unusual case of haemophilia. B. Lancet 1989; 1: 960.
9. Mandalaki T, Louizou C, Dimitriadou C, Briet E. Haemophilia.B Leyden in Greece. Thromb Haemost 1986;56: 340-2.
10. Liu PY, Beilin J, Meier C, Nguyen TV, Center JR, Leedman PJ, Seibel MJ, Eisman JA, Handelsman DJ. Age-related changes in serum testosterone and sex hormone binding globulin in Australian men: Longitudinal analyses of two geographically separate regional cohorts. J Clin Endocrinol Metab 2007; 92: 3599-603.
11. Hinks JL, Winship PR, Makris M, Preston FE, Peake IR, Goodeve AC. A rapid method for haemophilia.B mutation detection using conformation sensitive gel electrophoresis. Br J Haematol 1999; 104: 915-18.
12. Kurachi S, Deyashiki Y, Takeshita J, Kurachi K. Genetic mechanisms of age regulation of human blood coagulation factor IX. Science 1999; 285: 739-43.
13. Reijnen MJ, Maasdam D, Bertina RM, Reitsma PH. Haemophilia B Leyden: The effect of mutations at position +13 on the liver-specific transcription of the factor IX gene. Blood Coagul Fibrinolysis 1994; 5: 341-8.